[1]
Khalid Al Hawsawi, Bashair Al Zahrani, Hawazin Jan, Duaa Babkoor, Razan Alluhaibi, and Emad Alharbi, “Omalizumab in Chronic Spontaneous Urticaria: Assessment of Response in Twenty-Five Patients”, DER, vol. 7, no. 1, pp. 1–5, Jan. 2022.